These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28592128)

  • 1. Association of nuclear FOXP3 expression with low Ki67 index and better prognosis in patients with breast invasive ductal carcinoma.
    Li J; Zhang X; Zheng L; Liu Y
    Neoplasma; 2017; 64(5):754-761. PubMed ID: 28592128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients.
    Kim MH; Koo JS; Lee S
    Oncology; 2013; 85(2):128-36. PubMed ID: 23948758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
    Laurinavicius A; Green AR; Laurinaviciene A; Smailyte G; Ostapenko V; Meskauskas R; Ellis IO
    Oncotarget; 2015 Dec; 6(38):41134-45. PubMed ID: 26512778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
    Xu Y; Lan S; Zheng Q
    Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study.
    Zhao X; Li Y; Wang X; Wu J; Yuan Y; Lv S; Ren J
    Medicine (Baltimore); 2019 Dec; 98(50):e18403. PubMed ID: 31852159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
    Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
    Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters.
    Hashmi AA; Hashmi KA; Irfan M; Khan SM; Edhi MM; Ali JP; Hashmi SK; Asif H; Faridi N; Khan A
    BMC Res Notes; 2019 Sep; 12(1):605. PubMed ID: 31547858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
    Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
    Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
    Lin SC; Gan ZH; Yao Y; Min da L
    PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
    Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
    BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
    Liu N; Niu Y; Wang SL; Yu Q; Zhang RJ; Liu TJ
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1403-7. PubMed ID: 20646630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy.
    Ladoire S; Arnould L; Mignot G; Coudert B; Rébé C; Chalmin F; Vincent J; Bruchard M; Chauffert B; Martin F; Fumoleau P; Ghiringhelli F
    Breast Cancer Res Treat; 2011 Jan; 125(1):65-72. PubMed ID: 20229175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer.
    Chakravarty G; Moroz K; Makridakis NM; Lloyd SA; Galvez SE; Canavello PR; Lacey MR; Agrawal K; Mondal D
    Exp Biol Med (Maywood); 2011 Feb; 236(2):145-55. PubMed ID: 21321311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
    Li Y; Yang W; Yang Q; Zhou S
    Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of insulin-like growth factor-1 receptor expression in breast cancer.
    Şahin S; Cakir A; Gonul II; Seckin S; Uluoglu O
    Ann Ital Chir; 2020; 91():583-591. PubMed ID: 33554951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.